跳至主要内容
临床试验/ISRCTN76496973
ISRCTN76496973已完成不适用

Remote Ischemic Preconditioning to reduce Contrast-Induced Nephropathy: a blinded randomized controlled trial

Radboud University Nijmegen Medical Centre (Netherlands)0 个研究点目标入组 76 人开始时间: 2013年2月27日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
76

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Interventions with expected intravascular contrast volume > 100 mL:
  • 1.1. Thoracic Endovascular Aortic Repair (TEVAR)
  • 1.2. Endovascular Aortic Repair (EVAR)
  • 1.3. Digital Substraction Angiography (DSA)
  • 1.4. Percutaneous Transluminal Angioplasty (PTA)
  • 1.5. Percutaneous Intentional Endovascular Revascularisation (PIER)
  • 1.6. Carotic Artery Stenting (CAS)
  • 1.7. Percutaneous coiling/embolisation procedures
  • 1.8. Computed Tomographic Angiography
  • 2. High-risk of CIN (according CBO guideline):
  • 2.1. eGFR <45ml/min
  • 2.2. eGFR <60ml/min and diabetes
  • 2.3. eGFR <60ml/min ans 2 additional risk factors [peripheral artery disease, heart failure, >75 years, anaemia (Ht<0,39 for men and <0,36 for women), dehydration, use of diuretics and/or NSAID].
  • 3. Informed consent
  • 4. Both male and female, age > 18 years (no upper limit)

排除标准

  • 1. Age < 18 years
  • 2. Hemo- and peritoneal dialysis
  • 3. Concomitant inclusion in another interventional study
  • 4. Percutaneous coiling/embolisation procedures of the kidney

研究者

发起方
Radboud University Nijmegen Medical Centre (Netherlands)

相似试验